4.6 Article

Management and prognosis of locally recurrent rectal cancer - A national population-based study

Journal

EJSO
Volume 44, Issue 1, Pages 100-107

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejso.2017.11.013

Keywords

Rectal cancer; Local recurrence; Treatment; Treatment intention; Prognosis

Funding

  1. Stockholm Cancer Society
  2. Bengt Ihre Foundation
  3. Stockholm County Council
  4. Karolinska Institutet

Ask authors/readers for more resources

Background: The rate of local recurrence of rectal cancer (LRRC) has decreased but the condition remains a therapeutic challenge. This study aimed to examine treatment and prognosis in patients with LRRC in Sweden. Special focus was directed towards potential differences between geographical regions and time periods. Method: All patients with LRRC as first event, following primary surgery for rectal cancer performed during the period 1995-2002, were included in this national population-based cohort-study. Data were collected from the Swedish Colorectal Cancer Registry and from medical records. The cohort was divided into three time periods, based on the date of diagnosis of the LRRC. Results: In total, 426 patients fulfilled the inclusion criteria. Treatment with curative intent was performed in 149 patients (35%), including 121 patients who had a surgical resection of the LRRC. R0-resection was achieved in 64 patients (53%). Patients with a non-centrally located tumour were more likely to have positive resection margins (R1/R2) (OR 5.02, 95% CL2.25-11.21). Five-year survival for patients resected with curative intent was 43% after R0-resection and 14% after R1-resection. There were no significant differences in treatment intention or R0-resection rate between time periods or regions. The risk of any failure was significantly higher in R1-resected patients compared with R0-resected patients (HR 2.04, 95% CI:1.22-3.40). Conclusion: A complete resection of the LRRC is essential for potentially curative treatment. Time period and region had no influence on either margin status or prognosis. (C) 2017 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available